| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |